Karen O’Flynn

483 total citations
10 papers, 356 citations indexed

About

Karen O’Flynn is a scholar working on Clinical Psychology, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Karen O’Flynn has authored 10 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 2 papers in Pharmacology and 2 papers in Biological Psychiatry. Recurrent topics in Karen O’Flynn's work include Stress Responses and Cortisol (2 papers), Personality Disorders and Psychopathology (2 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Karen O’Flynn is often cited by papers focused on Stress Responses and Cortisol (2 papers), Personality Disorders and Psychopathology (2 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Karen O’Flynn collaborates with scholars based in Ireland, United States and Canada. Karen O’Flynn's co-authors include Timothy G. Dinan, Larry J. Siever, Harold W. Koenigsberg, James V. Lucey, Veronica O’Keane, Antonia S. New, Marianne Goodman, Randall E. Newmark, Erin A. Hazlett and Monte S. Buchsbaum and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Psychological Medicine.

In The Last Decade

Karen O’Flynn

10 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen O’Flynn Ireland 9 136 125 124 70 44 10 356
Vadim D. Khait United States 7 149 1.1× 139 1.1× 149 1.2× 143 2.0× 76 1.7× 8 485
M. Ansseau Belgium 11 142 1.0× 66 0.5× 104 0.8× 80 1.1× 78 1.8× 45 386
Erica L. Weiss United States 3 118 0.9× 89 0.7× 67 0.5× 110 1.6× 24 0.5× 5 472
Boris Rauchverger Israel 4 192 1.4× 80 0.6× 232 1.9× 104 1.5× 41 0.9× 5 378
Douglas Blackwood United Kingdom 8 64 0.5× 136 1.1× 155 1.3× 85 1.2× 84 1.9× 11 425
Stephen M. Stahl United States 8 67 0.5× 81 0.6× 135 1.1× 41 0.6× 93 2.1× 16 416
Oren Kalus United States 9 106 0.8× 89 0.7× 132 1.1× 93 1.3× 62 1.4× 11 359
J. Hallman Sweden 10 134 1.0× 143 1.1× 54 0.4× 25 0.4× 30 0.7× 16 424
Patrick Papart Belgium 14 87 0.6× 124 1.0× 116 0.9× 99 1.4× 138 3.1× 34 487
Laurence Guttmacher United States 8 134 1.0× 49 0.4× 139 1.1× 62 0.9× 79 1.8× 18 349

Countries citing papers authored by Karen O’Flynn

Since Specialization
Citations

This map shows the geographic impact of Karen O’Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen O’Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen O’Flynn more than expected).

Fields of papers citing papers by Karen O’Flynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen O’Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen O’Flynn. The network helps show where Karen O’Flynn may publish in the future.

Co-authorship network of co-authors of Karen O’Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Karen O’Flynn. A scholar is included among the top collaborators of Karen O’Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen O’Flynn. Karen O’Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Abi‐Dargham, Anissa, Lawrence S. Kegeles, Yolanda Zea‐Ponce, et al.. (2004). Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biological Psychiatry. 55(10). 1001–1006. 89 indexed citations
2.
New, Antonia S., Monte S. Buchsbaum, Erin A. Hazlett, et al.. (2004). Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology. 176(3-4). 451–458. 124 indexed citations
3.
Goodman, Marianne, Daniel S. Weiss, Harold W. Koenigsberg, et al.. (2003). The Role of Childhood Trauma in Differences in Affective Instability in Those With Personality Disorders. CNS Spectrums. 8(10). 763–770. 19 indexed citations
4.
O’Flynn, Karen, et al.. (1998). MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addiction Biology. 3(3). 309–314. 24 indexed citations
5.
O’Flynn, Karen, et al.. (1997). Gastrointestinal presentations of Munchausen's syndrome: three case reports. Irish Journal of Psychological Medicine. 14(4). 153–155. 3 indexed citations
6.
Lucey, James V., et al.. (1994). The Growth Hormone Response to Baclofen in Obsessive Compulsive Disorder: Does the GABA-B Receptor Mediate Obsessive Anxiety?. Pharmacopsychiatry. 27(1). 23–26. 10 indexed citations
7.
O’Flynn, Karen & Timothy G. Dinan. (1993). Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result. American Journal of Psychiatry. 150(11). 1728–1730. 27 indexed citations
8.
O’Keane, Veronica, Karen O’Flynn, James V. Lucey, & Timothy G. Dinan. (1992). Pyridostigmine-induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression. Psychological Medicine. 22(1). 55–60. 31 indexed citations
9.
Lucey, James V., Veronica O’Keane, Karen O’Flynn, Anthony W. Clare, & Timothy G. Dinan. (1991). Gender and Age Differences in the Growth Hormone Response to Pyridostigmine. International Clinical Psychopharmacology. 6(2). 105–110. 17 indexed citations
10.
O’Flynn, Karen, Veronica O’Keane, James V. Lucey, & Timothy G. Dinan. (1991). Effect of fluoxetine on noradrenergic mediated growth hormone release: A double blind, placebo-controlled study. Biological Psychiatry. 30(4). 377–382. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026